 | | | | April | | 7 | | 2021 | | 12:00 PM to 1:00 PM
US Eastern Time | |
|
| | | Validating a multiplex immunofluorescence
workflow to improve stratification of high-risk,
early-stage melanoma samples | | |
| |
| | | | In this webinar, viewers will: | |  | Learn about the benefits and limitations of quantitative multiplex immunofluorescence (qmIF) technology |
|
| | | | Find out how qmIF is used to stage patients with melanoma |
|
| | | | Discover how qmIF can lead to better treatment stratification of patients with melanoma |
|
| | | | Have the opportunity to ask questions during the live broadcast. |
|
| | |
| |
| | | | Speaker | | |  | | Yvonne Saenger, M.D. | Columbia University Herbert Irving Comprehensive Cancer Center
New York, NY |
| | | | | This webinar is produced by the Science/AAAS Custom Publishing Office,
and sponsored by Akoya Biosciences. |  |
|
|
|
|
No comments:
Post a Comment